Recent results from a small clinical trial raised confusing questions about the value of several widely used cholesterol medicines such as Zetia and its sister drug, Vytorin. The future of these drugs now depend on three large clinical trials that may show conclusively if the drugs reduce heart attacks and strokes. Currently underway, these trials are not expected to be completed until 2011. Yet, according to nutrition experts, diet still remains key to lowering cholesterol levels.
This entry was posted
on Wednesday, February 27th, 2008 at 9:00 am and is filed under Cholesterol.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.
